Get started
Author

Ryan Combs

Observed institution: Resonance (United States)
ORCID: 0000-0001-8795-4859
Observed ORCID: 0000-0001-8795-4859
OpenAlex ID: A5059039010
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry
2025 · Bertrand Pourroy, Maria D. Aumente, et al. · Cancers · 5
PDF
Long-Term Outcomes of 5-Fluorouracil-Related Early-Onset Toxicities: A Retrospective Cohort Study
2024 · Nicolás Tentoni, Ryan Combs, et al. · Cancers · 5
PDF
Protocol concordance and impact of protocol deviations on selected outcomes in delivery of high-dose methotrexate in acute lymphoblastic leukemia in Sri Lanka.
2020 · Sanjeeva Gunasekera, Geeth Vindula, et al. · Journal of Clinical Oncology · 2
P406: Incidence of Complications of High-dose Methotrexate Administration in Adults and Children With Hematologic Cancers: Preliminary Results From a European Registry
2023 · Scott Howard, Ryan Combs, et al. · HemaSphere · 1
Effect of access to care on outcomes of rural and elderly patients with primary central nervous system lymphoma.
2020 · Scott C. Howard, Nicholas Napier, et al. · Journal of Clinical Oncology · 1
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124
2026 · Bertrand Pourroy, Maria D. Aumente, et al. · Cancers
PDF
ALL-406: Comparison of Safe Delivery of 2 and 5 g/m2 of High-Dose Methotrexate to Children with Acute Lymphoblastic Leukemia in Sri Lanka without Availability of Methotrexate Levels
2020 · Sanjeeva Gunasekera, Geeth Vindula, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 7
Citation count: 14
H-index: 2
I10-index:
Year
Topic
Type